“…Furthermore, overexpression of WT-1 retarded induction of di erentiation of the HL-60 (Deuel et al, 1999) and U937 (Svedberg et al, 1998) AML cell lines and 32D cl3, a murine myeloblast cell line (Inoue et al, 1998). Also, high levels of WT-1 were detected in 68% of 600 AML and ALL samples (Miwa et al, 1992;Miyagi et al, 1993;Patmasiriwat et al, 1996;Schmid et al, 1997;Bergmann et al, 1997;Inoue et al, 1997;Im et al, 1999;Gaiger et al, 1999;Niegemann et al, 1999) and approximately 60% of MDS samples which were associated with advanced stages of the disease (Patmasiriwat et al, 1999;Tamaki et al, 1999). In summary, WT-1 is mutated in less than 10% of leukemia samples.…”